DocDollars

Array Biopharma Inc

CO · United States · Reporting entity ID 100000231820

Total reported 2019–2025
$72.3M
#130 of 2,960 reporting companies — 0.1% of all reported industry payments
$3.15M in general payments across 37,146 records, plus $69.1M in research funding across 5,497 records.

How it breaks down

General payments $3,152,660
Research funding $69,135,539

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Array Biopharma Inc reported $72.3M to US doctors and teaching hospitals from 2019 to 2025, ranking #130 of 2,960 reporting companies. 96% of that was research funding and 4% general payments such as consulting, speaking, food and travel. 37,146 general payment records and 5,497 research records were filed.

Common questions about Array Biopharma Inc

How much has Array Biopharma Inc paid US doctors?

Array Biopharma Inc reported $72,288,199 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $3,152,660 in general payments, $69,135,539 in research funding.

How does Array Biopharma Inc rank among drug and device companies?

It ranks #130 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Array Biopharma Inc mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.